RecruitingNot ApplicableNCT04603898

Oxalate Formation From Ascorbic Acid


Sponsor

University of Alabama at Birmingham

Enrollment

136 participants

Start Date

Nov 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this basic research study is to determine the contribution of endogenous ascorbic acid (AA) turnover to urinary oxalate excretion in both normal BMI and obese adult non-stone formers and calcium oxalate stone formers. The studies proposed will use diets of known nutrient composition, a stable isotope of ascorbic acid (13C6-AA) and mass spectrometric techniques to quantify ascorbic acid turnover to oxalate.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Carbon-13 Ascorbic Acid Oral Load and Low Oxalate Diet for people with kidney stone. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTLow Oxalate Diet

Subjects will be instructed to ingest a controlled diet low in oxalate for a total of 4 days

DIETARY_SUPPLEMENTCarbon-13 Ascorbic Acid Oral Load

Subjects will be instructed to ingest 1mg/kg of carbon-13 ascorbic acid at breakfast, 2 days after initiating the low oxalate controlled diet.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04603898


Related Trials